SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
MAXIMUS entered into a Second Amendment to its Credit Agreement adding $325 million in new term B loans, intended for debt repayment, stock repurchases, and working capital. The amendment creates a material direct financial obligation and represents a significant refinancing of the company's capital structure.
View raw filing on EDGAR →Taylor Patton's appointment as Chief Commercial and Marketing Officer is the principal disclosed action. While Henry L. Charlton's transition to a different senior role is also mentioned, the filing centers on the succession event—Patton succeeding Charlton in a C-suite commercial leadership position. This executive appointment at a major medical device company is material to investors assessing management continuity and strategic direction.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the Annual Meeting of Shareholders held on May 28, 2026. The filing reports the outcomes of four matters voted upon: election of eleven directors, approval of the say-on-pay proposal, approval of the Fifth Amended and Restated 2019 Stock Award and Incentive Plan, and ratification of KPMG as independent auditor. All results are presented with vote tallies (For, Against, Abstain) and broker non-votes, which is the standard format for Item 5.07 disclosures.
View raw filing on EDGAR →The filing discloses a press release announcing "RAD Construction Momentum Continues with Additional RIO and ROSA Orders," indicating new customer orders for the company's robotics products. While the specific financial impact is not quantified in the Item 8.01 disclosure itself, the announcement of material orders for the company's core products (RIO and ROSA robots) would reasonably affect an investor's assessment of business momentum and revenue prospects. This does not fit neatly into earnings_release (no financial results disclosed) but represents a material business development that warrants disclosure under Item 8.01.
View raw filing on EDGAR →Lennox International held its Annual Meeting of stockholders on May 21, 2026, with voting results on three proposals: election of three Class I Directors, an advisory vote on named executive officer compensation (which received approximately 98% approval), and ratification of Ernst & Young LLP as independent auditor.
View raw filing on EDGAR →The filing discloses an amendment to a distribution agreement that extends the Company's ability to offer and sell up to $600 million in common stock shares through an at-the-market (ATM) offering program. While the amendment itself is primarily administrative (extending the expiration date and updating settlement terms), it preserves and extends a material equity issuance facility that could result in significant dilution to existing shareholders. The $600 million offering capacity represents a substantial potential dilutive issuance, making this material to investors assessing shareholder dilution risk.
View raw filing on EDGAR →Red River Bancshares appointed two new directors, A. Peyton Bush, IV and R. Chance DeWitt, M.D., to the board effective May 28, 2026, with independence determinations and committee assignments disclosed.
View raw filing on EDGAR →The Company received approximately $50.4 million in net proceeds from the sale of substantially all assets of New APR, in which it held a 5% non-voting ownership interest. This represents a material disposition event that would significantly affect investor assessment of the registrant's liquidity and asset base, with an additional $9.9 million held in escrow. The magnitude of proceeds ($50.4M) relative to a small-cap company (DUOT) makes this material.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on May 28, 2026, covering three matters: election of nine directors, ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each matter, which is the hallmark of Item 5.07 shareholder vote results disclosures and is material to investors assessing board composition and governance.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from DexCom's 2026 Annual Meeting of Stockholders held on May 27, 2026. The filing reports voting outcomes for three proposals: election of twelve directors, ratification of Deloitte & Touche LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →Shareholders approved multiple material proposals at a special meeting held on May 27, 2026, including the Business Combination Agreement with Factorial Inc., domestication from Cayman Islands to Delaware, stock issuances for the PIPE investment and business combination, and election of seven directors.
View raw filing on EDGAR →The filing discloses the appointment of Eric Batis to the Board of Directors on May 21, 2026, as the principal action. While the section also mentions the resignations of two directors (Stefani Danielle Carter and Rebecca Musser), the substantive focus and detail is on Batis's appointment, his qualifications as COO of Ashford Inc., and his extensive operational and investment background. The appointment of a new board member with significant operational experience at a related company is material to investors assessing board composition and governance.
View raw filing on EDGAR →The Board of Directors authorized a $1.0 billion share repurchase program, representing a material capital allocation decision that affects shareholder value and the company's financial flexibility.
View raw filing on EDGAR →The filing discloses a press release announcing "condensed consolidated financial results of the Company for the fourth quarter and fiscal year ended March 31, 2026," which is a standard earnings release. Item 2.02 is the designated item for Results of Operations and Financial Condition, and the attachment of a press release with quarterly and annual financial results is the classic structure for earnings_release events.
View raw filing on EDGAR →CECO Environmental held its annual stockholders meeting on May 27, 2026, and disclosed voting results for six proposals including director elections, advisory compensation vote, equity plan approval, auditor ratification, and critically, approval of stock consideration for the Thermon merger. The approval of the stock issuance proposal satisfies a key closing condition for the contemplated mergers.
View raw filing on EDGAR →Stockholders approved the CECO Equity Plan (2026 Plan), which provides for the grant of up to 3,350,000 shares of Company Common Stock to officers and directors, succeeding the 2021 Plan. This represents a material amendment to executive compensation arrangements.
View raw filing on EDGAR →Thermon stockholders approved the Thermon Merger Proposal at a special meeting held on May 27, 2026, with 28,766,607 votes in favor, satisfying a key closing condition for the contemplated merger with CECO. Stockholders also voted on an advisory vote regarding executive compensation in connection with the merger and an adjournment proposal.
View raw filing on EDGAR →The filing discloses ConnectM Technology Solutions' financial results for the quarter ended March 31, 2026, via a press release attached as Exhibit 99.1. This is a standard quarterly earnings release under Item 2.02, which is material to investors as it provides essential information about the company's operational and financial performance.
View raw filing on EDGAR →The Company announced formal certification by NOAA of its USA B exploration license application under the Deep Seabed Hard Mineral Resources Act. This represents a significant regulatory milestone for the Company's deep-sea mining operations and would materially affect investor assessment of the registrant's ability to pursue its core business strategy. While not fitting neatly into standard M&A or operational categories, the certification of an exploration license is a material event that a reasonable investor would consider important to the registrant's prospects.
View raw filing on EDGAR →Lulu's Fashion Lounge received a Nasdaq notification on May 21, 2026 that it is out of compliance with the minimum $2.5 million stockholders' equity requirement (Nasdaq Listing Rule 5550(b)(1)), with reported stockholders' equity of approximately $(525) thousand as of March 29, 2026. The company has 45 calendar days to submit a compliance plan and up to 180 days to regain compliance, with no assurance of success. This is a classic delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →Peter Pitts was appointed as a director of Brainstorm Cell Therapeutics effective May 25, 2026, expanding the Board from seven to eight directors. The appointment was approved by the Board and disclosed via press release on May 28, 2026.
View raw filing on EDGAR →The Compensation Committee adopted the 2027 Variable Compensation Plan on May 26, 2026, establishing cash bonus arrangements for executive officers including CEO Lee-Lean Shu ($275,000 target) and other executives ($137,500 target each). The disclosure details performance criteria, vesting schedules, and potential bonus multipliers up to 2x target, which constitutes a material compensatory arrangement requiring 8-K disclosure under Item 5.02(e).
View raw filing on EDGAR →PENN Entertainment amended its $962.5 million Term Loan B facility on May 28, 2026, repricing the interest rate margins downward (from 2.50% to 2.00% for SOFR loans) and extending the maturity to May 2033. This debt refinancing materially affects the company's debt structure and cost of capital.
View raw filing on EDGAR →The filing discloses adjournment of a stockholder meeting related to a "proposed transaction between TWO and CrossCountry Intermediate Holdco, LLC," which constitutes material M&A activity. Although the disclosure focuses on the procedural adjournment rather than execution of the deal itself, the underlying transaction with CrossCountry Mortgage is a material acquisition or change-of-control event that would significantly affect investors' assessment of the registrant.
View raw filing on EDGAR →Andrew Safran was appointed to the Board of Directors of Ferrellgas, Inc. on May 21, 2026, bringing significant energy and investment banking experience. Pamela A. Breuckmann was appointed to Vice Chair of the Board. These board appointments and promotion represent material governance changes affecting the company's strategic direction.
View raw filing on EDGAR →Medalist's subsidiary OWN has entered into a $15.8 million Pledged Asset Line (PAL) Agreement with Charles Schwab, a material financing arrangement secured by a brokerage account. While this is a credit facility disclosure rather than a covenant breach or going-concern issue, the establishment of a significant margin credit facility with customary default triggers (including bankruptcy initiation and collateral insufficiency) is material to investors assessing the company's liquidity and financial obligations, but does not fit neatly into the more specific event categories.
View raw filing on EDGAR →The filing discloses two distinct events: (1) a segment reorganization moving a titanium alloy location from Engine Products to Engineered Structures, which the company explicitly states had "no impact on the Company's consolidated results, financial position or cash flows" and is not a restatement; and (2) a material debt refinancing transaction on May 22, 2026, involving early prepayment of ¥29,702 million in JPY Term Loan debt and entry into a cross-currency swap on $300 million of 6.750% Notes due 2028, expected to reduce annual interest expense by approximately $12 million. The segment reorganization is administrative and immaterial, but the debt refinancing is a material financial transaction affecting the company's capital structure and interest expense. This combination does not fit cleanly into a single taxonomy category (not a restatement, not a covenant breach, not M&A), making "other_material" the most appropriate classification.
View raw filing on EDGAR →The filing discloses the appointment of Jason B. Rush as Chairman of the Board on May 27, 2026, following his election to the Board at the May 7, 2026 annual meeting. While Rush was already serving as President and CEO (appointed January 1, 2026), the principal disclosed action here is his elevation to Chairman, a material executive appointment. The extensive employment history and compensation reference underscore the significance of this role change.
View raw filing on EDGAR →The Board approved a $40 million share repurchase program on May 28, 2026, which is a material capital allocation decision that would affect investor assessment of the company's financial strategy and use of cash. While share repurchases are common corporate actions, a $40 million authorization represents a significant commitment of capital and signals management's confidence in valuation. This does not fit neatly into the more specific event categories (it is not an earnings release, executive change, M&A activity, or financial restatement), making "other_material" the most appropriate classification.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Merck's Annual Meeting of Shareholders held on May 26, 2026, filed under Item 5.07. The filing reports voting outcomes on six matters: election of 13 directors, advisory vote on named executive officer compensation, ratification of the independent auditor, and three shareholder proposals. All proposals passed with majority support, and the detailed vote tallies (votes for, against, abstentions, and broker non-votes) are provided for each matter, which is material to investors' understanding of shareholder governance and company direction.
View raw filing on EDGAR →Hudson Technologies received a bridge modification from the Defense Logistics Agency extending an existing contract expiration from July 29, 2026 to November 29, 2026, with two additional three-month renewal options. While this is a material contract extension for a significant government customer (DLA), it does not fit neatly into the more specific event categories (not M&A, not an impairment, not a covenant breach). The extension of a major defense contract is material to investor assessment of the company's revenue continuity and operational stability, warranting disclosure as an other_material event.
View raw filing on EDGAR →ClearSign suspended and terminated its ATM (At The Market) prospectus supplement on May 26, 2026, halting the ability to sell up to $10.39 million in common stock under the ATM Agreement. While this is a material event affecting the company's capital-raising capacity, it does not fit cleanly into the dilutive_issuance category (which applies to actual unregistered sales) nor any other specific taxonomy event. The suspension of an active equity offering program is material to investors assessing the company's liquidity and financing flexibility, warranting disclosure as other_material.
View raw filing on EDGAR →Kathleen Shea Ballay, the Company's General Counsel and Chief Legal Officer, has announced her resignation effective July 3, 2026. This is a clear departure of a named executive officer responsible for legal affairs, a material position at any public company. The departure of a General Counsel and Chief Legal Officer is material to investors as it affects governance and legal oversight.
View raw filing on EDGAR →Aflac issued approximately ¥65.9 billion in registered senior notes across four tranches (2029, 2031, 2033, and 2036) on May 28, 2026, pursuant to a public offering under Form S-3ASR. While this is a material debt issuance that would affect a reasonable investor's assessment of the company's capital structure and financial position, it does not fit cleanly into the more specific event categories. This is a registered debt offering (not an unregistered equity issuance triggering dilutive_issuance), not a covenant breach, and not an M&A activity. The disclosure is material but best classified as other_material given the taxonomy's focus on equity issuances and specific debt-related events like covenant breaches.
View raw filing on EDGAR →First National Funding LLC entered into material definitive agreements on May 28, 2026, including a Series 2026-1 Indenture Supplement with First National Master Note Trust and U.S. Bank Trust Company, and a Risk Retention Agreement with First National Bank of Omaha, establishing a securitization structure for asset-backed financing.
View raw filing on EDGAR →First National Master Note Trust issued $500 million in publicly offered Class A Asset Backed Notes on May 28, 2026, along with $67.3 million and $73.7 million in Class B and C notes sold to an affiliate, with net proceeds of $497.5 million used to purchase credit card receivables.
View raw filing on EDGAR →The filing discloses a registered direct offering of 8,539,709 shares of common stock at $0.5855 per share, generating approximately $5.0 million in gross proceeds. Additionally, the Company amended outstanding warrants to reduce the exercise price from a weighted average of $1.78 to $0.5855 per share, affecting 15,488,570 shares. This is a material dilutive equity issuance that would significantly affect shareholder ownership and is disclosed under Item 8.01 as a registered direct offering.
View raw filing on EDGAR →Target Hospitality entered into an underwriting agreement on May 28, 2026 for a registered public offering of 7,000,000 shares of common stock at $17.00 per share, with an additional 30-day option for 1,050,000 shares. Although the Company itself receives no proceeds (the selling stockholders are TDR Capital-controlled entities), this is a material dilutive equity issuance that increases shares outstanding and affects existing shareholders' ownership percentages. The disclosure of a registered public offering of this magnitude is material to investors.
View raw filing on EDGAR →The filing discloses an increase to the maximum aggregate offering amount under an At Market Issuance Sales Agreement (ATM offering) by $2,956,000 in common stock. This is a dilutive equity issuance that expands the company's ability to raise capital through unregistered or registered equity sales, which materially affects shareholder dilution and the company's capital structure. The company has already sold approximately $3,445,000 under the prior supplement, indicating active use of this facility.
View raw filing on EDGAR →The filing explicitly discloses that Photronics issued a press release on May 28, 2026 reporting second quarter fiscal 2026 financial results, with the press release furnished as Exhibit 99.1. This is a standard earnings release disclosure under Item 2.02, which would materially affect a reasonable investor's assessment of the company's financial performance.
View raw filing on EDGAR →Ionis disclosed positive Phase 3 pivotal trial results for bepirovirsen, a partnered investigational drug for chronic hepatitis B licensed to GSK, demonstrating a 19% functional cure rate and meeting primary endpoints with clinical efficacy superior to standard of care. This material clinical milestone affects investor assessment of the company's pipeline prospects and partnership value.
View raw filing on EDGAR →This is a Form 8-K Item 5.07 disclosure of shareholder meeting results. Although Proposal 1 was not ultimately submitted to a vote due to lack of quorum, the filing reports on the reconvened special meeting held on May 21, 2026, and discloses voting results for the Series I preferred stockholder and common stockholders on Proposal 1 (which sought to eliminate a supermajority voting requirement). The disclosure of shareholder voting activity and meeting outcomes is the core purpose of Item 5.07, making this a shareholder_vote_results event. The failure to achieve quorum and the resulting non-submission of the proposal is material information affecting the company's governance structure.
View raw filing on EDGAR →ePlus Inc. announced financial results for its fourth quarter and fiscal year ended March 31, 2026, via press release attached as Exhibit 99.1, including reconciliation of GAAP and non-GAAP measures.
View raw filing on EDGAR →The filing discloses termination of the 2027 Notes ($400 million principal) through redemption using proceeds from a new $400 million 2031 Notes issuance. While this involves debt refinancing, it does not fit cleanly into the standard taxonomy: it is neither a covenant breach (no default triggered), nor a material impairment, nor a dilutive equity issuance. The event is material to investors as it affects the company's capital structure and debt maturity profile, but the specific mechanics—a routine debt refinancing—lack the acute financial distress signals of other categories.
View raw filing on EDGAR →The Fund reported its NAV per share of $26.10 as of April 30, 2026, aggregate NAV of $1,625.2 million, and key leverage metrics including a debt-to-equity ratio of 0.91x, along with progress on its continuous $2.5 billion public offering. This disclosure is material to investors assessing the fund's capital structure and growth trajectory.
View raw filing on EDGAR →The filing discloses the appointment of Matt McLaughlin as Chief Executive Officer of comScore, Inc., announced via press release on May 28, 2026. The appointment of a CEO is a material executive change that would affect a reasonable investor's assessment of the company's leadership and direction. Although disclosed under Item 7.01 (Regulation FD Disclosure) rather than the typical Item 5.02, the substance is clearly an executive appointment.
View raw filing on EDGAR →Sono-Tek Corporation disclosed financial results for the fiscal year ended February 28, 2026, via a press release issued on May 28, 2026 and furnished under Regulation FD.
View raw filing on EDGAR →Gideon Yu, a Board member since 2021 and member of the Nominating and Corporate Governance Committee and Risk, Compliance and Planning Committees, resigned effective immediately on May 22, 2026.
View raw filing on EDGAR →Hanmi Financial held its Annual Meeting of Stockholders on May 27, 2026, with voting results disclosed on four matters: election of ten board directors, advisory vote on executive compensation, approval of the 2026 Employee Stock Purchase Plan, and ratification of Crowe LLP as independent auditor.
View raw filing on EDGAR →Hadron Energy Operating Company completed a material business combination with GigCapital7 Corp on May 22, 2026, resulting in a change of control, company rename to Hadron Energy, Inc., and new Nasdaq ticker symbols (HDRN/HDRNW). The filing also discloses entry into ancillary definitive agreements (Registration Rights Agreement and Lock-Up Agreement) in connection with the closing of the business combination.
View raw filing on EDGAR →